Cue Biopharma is trading 6.9% up now at $30.71, with no clear catalyst identified.
- No company-specific announcement or analyst action dated September 14, 2026, was found to explain the move.
- Latest listed releases are older developments, including the August 3 CUE-221 IND submission announcement.
- Volume is 121.43K versus a 132.49K average; broader indexes are declining, with no clear sector or global explanation.